SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
-9.52%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$649M
AUM Growth
-$92.5M
(-12%)
Cap. Flow
-$6.29M
Cap. Flow
% of AUM
-0.97%
Top 10 Holdings %
Top 10 Hldgs %
38.79%
Holding
84
New
16
Increased
18
Reduced
18
Closed
18
Top Buys
| 1 |
United Therapeutics
UTHR
|
$25.4M |
| 2 |
Illumina
ILMN
|
$21.8M |
| 3 |
OraSure Technologies
OSUR
|
$20.7M |
| 4 |
Hologic
HOLX
|
$17.3M |
| 5 |
Arcellx
ACLX
|
$13.9M |
Top Sells
| 1 |
Lantheus
LNTH
|
$87.7M |
| 2 |
AstraZeneca
AZN
|
$24.3M |
| 3 |
C4 Therapeutics
CCCC
|
$9.57M |
| 4 |
Enanta Pharmaceuticals
ENTA
|
$8.24M |
| 5 |
Smith & Nephew
SNN
|
$6.64M |
Sector Composition
| 1 | Healthcare | 95.72% |
| 2 | Financials | 0.6% |
| 3 | Consumer Staples | 0.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Lyra Therapeutics
LYRA
$11.8M
| – | – |
-200
| Closed | -$44K |
|
77
Vanda Pharmaceuticals
VNDA
$279M
| – | – |
-158,700
| Closed | -$2.49M |
|
78
SPDR S&P Biotech ETF
XBI
$5.29B
| – | – |
0
| – | – |
|
|
CUTR
79
DELISTED
Cutera, Inc.
CUTR
| – | – |
-86,180
| Closed | -$3.56M |
|
|
NGM
80
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| – | – |
-13,000
| Closed | -$230K |
|
|
KDNY
81
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| – | – |
-298,700
| Closed | -$4.87M |
|
|
CCXI
82
DELISTED
ChemoCentryx, Inc.
CCXI
| – | – |
-68,320
| Closed | -$2.49M |
|
|
ARNA
83
DELISTED
Arena Pharmaceuticals Inc
ARNA
| – | – |
-40,000
| Closed | -$3.72M |
|